Browsing by Subject "A61K 31/337"
Now showing items 1-7 of 7
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-09-15)The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-01-16)The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-01-10)The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-05-30)The present invention provides optical agents comprising optically functional cross linked supramolecular structures and assemblies useful for tandem optical imaging and therapy. Supramolecular structures and assemblies ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-11-15)In some embodiments, the present invention provides methods of treating a tumor in a subject. In some embodiments, the methods may include a step of administering to the subject a therapeutic composition that comprises: ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-09-22)The present invention provides a biodegradable “precision polymer system” (poly system) and methods for preparing pharmaceutically effective “precision polymer nanosystems” (polymer nanosystem) for delivery and/or targeting ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-01-17)The present disclosure generally relates to polymer-drug systems, and more particularly to nanoscopic particles comprising amphiphilic block copolymers conjugated, physically encapsulated, or otherwise combined with ...